JP2022522312A5 - - Google Patents

Info

Publication number
JP2022522312A5
JP2022522312A5 JP2021559054A JP2021559054A JP2022522312A5 JP 2022522312 A5 JP2022522312 A5 JP 2022522312A5 JP 2021559054 A JP2021559054 A JP 2021559054A JP 2021559054 A JP2021559054 A JP 2021559054A JP 2022522312 A5 JP2022522312 A5 JP 2022522312A5
Authority
JP
Japan
Prior art keywords
unsubstituted
substituted
alkyl
monocyclic
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021559054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022522312A (ja
JP7627008B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/026116 external-priority patent/WO2020205934A1/en
Publication of JP2022522312A publication Critical patent/JP2022522312A/ja
Publication of JP2022522312A5 publication Critical patent/JP2022522312A5/ja
Priority to JP2024101773A priority Critical patent/JP7710215B2/ja
Application granted granted Critical
Publication of JP7627008B2 publication Critical patent/JP7627008B2/ja
Priority to JP2025110439A priority patent/JP7811768B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559054A 2019-04-03 2020-04-01 ピロール化合物 Active JP7627008B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024101773A JP7710215B2 (ja) 2019-04-03 2024-06-25 ピロール化合物
JP2025110439A JP7811768B2 (ja) 2019-04-03 2025-06-30 ピロール化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962828919P 2019-04-03 2019-04-03
US62/828,919 2019-04-03
US201962932686P 2019-11-08 2019-11-08
US62/932,686 2019-11-08
PCT/US2020/026116 WO2020205934A1 (en) 2019-04-03 2020-04-01 Pyrrole compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024101773A Division JP7710215B2 (ja) 2019-04-03 2024-06-25 ピロール化合物

Publications (3)

Publication Number Publication Date
JP2022522312A JP2022522312A (ja) 2022-04-15
JP2022522312A5 true JP2022522312A5 (enExample) 2023-04-11
JP7627008B2 JP7627008B2 (ja) 2025-02-05

Family

ID=72667046

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021559054A Active JP7627008B2 (ja) 2019-04-03 2020-04-01 ピロール化合物
JP2024101773A Active JP7710215B2 (ja) 2019-04-03 2024-06-25 ピロール化合物
JP2025110439A Active JP7811768B2 (ja) 2019-04-03 2025-06-30 ピロール化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024101773A Active JP7710215B2 (ja) 2019-04-03 2024-06-25 ピロール化合物
JP2025110439A Active JP7811768B2 (ja) 2019-04-03 2025-06-30 ピロール化合物

Country Status (23)

Country Link
US (3) US11191747B2 (enExample)
EP (2) EP4733305A2 (enExample)
JP (3) JP7627008B2 (enExample)
KR (2) KR102933784B1 (enExample)
CN (4) CN121108034A (enExample)
AU (2) AU2020253444C1 (enExample)
BR (1) BR112021019817A2 (enExample)
CA (1) CA3134635A1 (enExample)
CL (1) CL2021002575A1 (enExample)
CO (1) CO2021014210A2 (enExample)
DK (1) DK3947349T3 (enExample)
FI (1) FI3947349T3 (enExample)
GE (2) GEAP202515762A (enExample)
IL (1) IL286902B2 (enExample)
MA (1) MA55564A (enExample)
MX (1) MX2021012105A (enExample)
PE (1) PE20220252A1 (enExample)
PH (1) PH12021552513A1 (enExample)
PT (1) PT3947349T (enExample)
SG (1) SG11202110718PA (enExample)
TW (1) TWI846853B (enExample)
UA (1) UA129029C2 (enExample)
WO (1) WO2020205934A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102933784B1 (ko) 2019-04-03 2026-03-06 알리고스 테라퓨틱스 인코포레이티드 피롤 화합물
WO2022143610A1 (zh) * 2020-12-29 2022-07-07 广东东阳光药业有限公司 新型酰胺吡咯类化合物及其在药物中的应用
WO2022156758A1 (zh) * 2021-01-22 2022-07-28 广东东阳光药业有限公司 新型酰胺吡咯类化合物及其在药物中的用途
CN118201942A (zh) 2021-09-08 2024-06-14 阿利戈斯治疗公司 经修饰的短干扰核酸(siNA)分子和其用途
CN116768776B (zh) * 2022-03-17 2024-07-02 成都微芯药业有限公司 吡咯酰胺类化合物及其制备方法和用途
CN116120219A (zh) * 2022-12-27 2023-05-16 吉斯凯(苏州)制药有限公司 一种多取代吡咯类化合物及其制备方法和在制备hbv衣壳蛋白抑制剂中的应用
AU2024212652A1 (en) * 2023-01-26 2025-07-10 Aligos Therapeutics, Inc. Hepatitis b combination therapies

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784782A (en) 1986-03-27 1988-11-15 The Lubrizol Corporation Heterocyclic compounds useful as additives for lubricant and fuel compositions
WO2002006278A1 (en) 2000-07-17 2002-01-24 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2002085908A1 (en) 2001-04-24 2002-10-31 Purdue Research Foundation Folate mimetics and folate-receptor binding conjugates thereof
US6956040B2 (en) 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
GB0119172D0 (en) 2001-08-06 2001-09-26 Melacure Therapeutics Ab Phenyl pyrrole derivatives
NZ541234A (en) 2002-12-20 2008-06-30 Amgen Inc Asthma and allergic inflammation modulators
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
GB2398299A (en) 2003-02-13 2004-08-18 Melacure Therapeutics Ab Pharmaceutically active phenyl-pyrrole derivatives
US20070191336A1 (en) 2003-12-24 2007-08-16 Flynn Daniel L Anti-inflammatory medicaments
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
AU2005221959C1 (en) 2004-03-13 2010-06-17 Kyoto University Novel indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug each comprising the same
US20060105355A1 (en) 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer having a linker moiety
US20060102471A1 (en) 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer
WO2006092059A1 (en) 2005-03-04 2006-09-08 Fan Wu Design and synthesis of novel antimicrobials
US20100234379A1 (en) 2005-07-28 2010-09-16 Bahr Ben A Dual modulation of endocannabinoid transport and fatty-acid amide hydrolase for treatment of excitotoxicity
US20070065877A1 (en) 2005-09-19 2007-03-22 Combimatrix Corporation Microarray having a base cleavable succinate linker
WO2008033562A2 (en) 2006-09-15 2008-03-20 Xcovery, Inc. Kinase inhibitor compounds
CA2688136A1 (en) 2007-06-08 2008-12-11 Advinus Therapeutics Private Limited Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
CA2690243A1 (en) 2007-06-18 2008-12-24 Sanofi-Aventis Pyrrole derivatives as p2y12 antagonists
CA2754492A1 (en) 2009-03-05 2010-09-10 Purdue Research Foundation Method for early imaging of atherosclerosis
EP2408770B1 (en) 2009-03-20 2014-11-05 University Of Virginia Patent Foundation Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
JP2013508413A (ja) 2009-10-22 2013-03-07 ヴァンダービルト ユニバーシティー ｍＧｌｕＲ４アロステリック増強剤、組成物、および神経機能不全を治療する方法
RU2012154447A (ru) 2010-05-12 2014-06-20 Вандербилт Юниверсити Гетероциклические сульфоновые аллостерические потенциаторы mglur4, композиции и способы лечения неврологических дисфункций
BR112012032247A2 (pt) 2010-06-15 2015-09-15 Bayer Ip Gmbh derivados de ácido antranílico
SI2616444T1 (sl) 2010-09-14 2016-03-31 Instytut Biochemii I Biofizyki Pan Spojine kot modulatorji mutantnega cftr proteina in njihova uporaba za zdravljenje bolezni, povezanih s cftr proteinsko okvaro
WO2012047525A2 (en) 2010-09-27 2012-04-12 Endocyte, Inc. Folate conjugates for treating inflammation of the eye
WO2012078902A2 (en) 2010-12-08 2012-06-14 Proteostasis Therapeutics, Inc. Proteostasis regulators
WO2012087976A2 (en) 2010-12-21 2012-06-28 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
WO2012154880A1 (en) 2011-05-09 2012-11-15 Proteostasis Therapeutics, Inc. Proteostasis regulators for treating cystic fibrosis and other protein misfolding diseases
US20130072473A1 (en) 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
RS58718B1 (sr) 2011-05-12 2019-06-28 Proteostasis Therapeutics Inc Regulatori proteostaze
JP5977347B2 (ja) 2011-07-01 2016-08-24 バルーク エス．ブルームバーグ インスティテュート Ｈｂｖ感染に対する抗ウイルス剤としてのスルファモイルベンズアミド誘導体
US8835640B1 (en) 2011-11-16 2014-09-16 Paresh T. Gandhi Nicotine derivatives
HK1210969A1 (en) 2012-01-20 2016-05-13 奥克塞拉有限公司 Substituted heterocyclic compounds for disease treatment
EP3345597A3 (en) 2012-09-19 2018-08-22 Faller & Williams Technology, LLC Pkc delta inhibitors for use as therapeutics
JO3583B1 (ar) 2013-05-17 2020-07-05 Janssen Sciences Ireland Uc مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
NO3024819T3 (enExample) 2013-07-25 2018-07-21
MX368158B (es) 2013-10-23 2019-09-20 Janssen Sciences Ireland Uc Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b.
CN104672221B (zh) 2013-11-29 2018-01-23 中国科学院上海有机化学研究所 一种氟代苯并杂环‑杂芳环结构的合成方法
WO2015134539A1 (en) 2014-03-03 2015-09-11 The Regents Of The University Of California Mcl-1 antagonists
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
US20160166679A1 (en) 2014-12-12 2016-06-16 Purdue Research Foundation Method of treatment using folate conjugates and tyrosine kinase inhibitors
KR101726060B1 (ko) 2015-07-28 2017-04-12 한양대학교 산학협력단 디피롤 유도체와 금속 염을 포함하는 염화수소 가스 검출용 조성물 및 이를 포함하는 염화수소 가스 검출용 색변환 센서
KR101726059B1 (ko) 2015-07-28 2017-04-12 한양대학교 산학협력단 디피롤 유도체와 암모늄 염을 포함하는 브롬화수소 가스 검출용 조성물 및 이를 포함하는 브롬화수소 가스 검출용 색변환 센서
WO2017081615A1 (en) 2015-11-09 2017-05-18 Wockhardt Limited 7-oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections
AU2017231817B2 (en) 2016-03-09 2021-02-25 Emory University Elimination of hepatitis B virus with antiviral agents
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
CN108250121A (zh) 2016-12-28 2018-07-06 上海长森药业有限公司 磺酰胺-芳基酰胺类化合物及其治疗乙型肝炎的药物用途
CA3094022A1 (en) 2018-03-30 2019-10-03 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
CA3113109A1 (en) 2018-10-05 2020-04-09 Emory University Monomer and multimeric anti-hbv agents
US11096931B2 (en) 2019-02-22 2021-08-24 Janssen Sciences Ireland Unlimited Company Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
KR102933784B1 (ko) 2019-04-03 2026-03-06 알리고스 테라퓨틱스 인코포레이티드 피롤 화합물
US11903924B2 (en) 2019-11-13 2024-02-20 Xi'an Xintong Pharmaceutical Research Co., Ltd. HBV inhibitor and its use
WO2022143610A1 (zh) 2020-12-29 2022-07-07 广东东阳光药业有限公司 新型酰胺吡咯类化合物及其在药物中的应用

Similar Documents

Publication Publication Date Title
CA2389745A1 (en) Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
JP2010514768A5 (enExample)
KR20030032927A (ko) 뉴클레오시드 화합물 및 이들의 용도
JP2005533824A5 (enExample)
US20060074035A1 (en) Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections
CA2632626A1 (en) Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
PL409123A1 (pl) Związki, ich zastosowanie i kompozycje do leczenia wirusowego zapalenia wątroby typu C
JP2022529466A5 (enExample)
JP2022534501A5 (enExample)
JP2022505597A5 (enExample)
JP2008523098A5 (enExample)
JP2017512789A5 (enExample)
RU2012132218A (ru) Соединения и фармацевтические композиции для лечения вирусных инфекций
CN110684067A (zh) 取代的核苷和核苷酸
RS61064B1 (sr) Modulatori proteina jezgra hepatitisa b
JP2006516949A5 (enExample)
JP2017519780A5 (enExample)
JP2004513070A5 (enExample)
JP2004525142A5 (enExample)
RU2009141187A (ru) Серосодержащие соединения как ингибиторы ns3 серинпротеазы вируса гепатита с
JP2012519691A5 (enExample)
JP2021526017A5 (enExample)
JP2022501370A5 (enExample)
JPH11512083A (ja) Ｃ型肝炎の治療における１，３−オキサチオランヌクレオシドアナログ
JP2017521433A5 (enExample)